Hong Kong SAR

If ever there was competition in the overnight block market in Hong Kong, then Wednesday was it: four deals were priced to raise a combined $630m.

Standard Chartered is strengthening its credit teams in Singapore, Hong Kong, London and New York, the bank said this week.

WuXi BioLogics, which is planning a $200m-$300m IPO in Hong Kong, is set to begin investor education next week if the stock exchange grants it approval at a listing hearing on May 15, said a banker close to the deal.

A Hong Kong-based banker in the Asia Pacific leveraged finance team of HSBC has resigned, and is understood to be heading to Bank of America Merrill Lynch, according to sources.

Hong Kong developer Cheung Kong Property Holdings (CKP) and Chinese company Huachen Energy Co both opened books for new dollar deals on Thursday.

Three Hong Kong-based managing directors at UBS, Wang Cheng, Ding Xiaowen and Frank Sun, have left the firm, according to sources familiar with the matter.

Hong Kong’s Bank of East Asia launched a new Basel III additional tier one dollar deal on Thursday morning, following a roadshow earlier in the week.

CK Hutchison priced a $1bn hybrid bond at 4% on Tuesday, with the deal featuring a dual step-up to qualify for partial equity treatment from ratings agencies. And while investor appetite was strong, some handholding was needed behind the scenes.

The head of credit for Axis Bank in Hong Kong has been promoted, with the scope of his role widening following the bump up.

BoCom International Holdings Co has covered its HK$2.1bn ($265.6m) IPO after opening books last Friday with a strong cornerstone base, according to a banker on the deal.

Former UBS banker Paul Au has resurfaced as the new head of fixed income at CMB International.

AMTD Strategic Capital Group, the insurance brokerage arm of AMTD Group, is planning to list in Hong Kong, according to a filing with the stock exchange on Monday.